Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 9 July 1999:
Vol. 285. no. 5425, pp. 248 - 251
DOI: 10.1126/science.285.5425.248

Reports

HMG-1 as a Late Mediator of Endotoxin Lethality in Mice

Haichao Wang, 13* Ona Bloom, 3 Minghuang Zhang, 3 Jaideep M. Vishnubhakat, 3 Michael Ombrellino, 23 Jiantu Che, 3 Asia Frazier, 23 Huan Yang, 3 Svetlana Ivanova, 3 Lyudmila Borovikova, 3 Kirk R. Manogue, 3 Eugen Faist, 4 Edward Abraham, 5 Jan Andersson, 6 Ulf Andersson, 7 Patricia E. Molina, 2 Naji N. Abumrad, 2 Andrew Sama, 1 Kevin J. Tracey 23

Endotoxin, a constituent of Gram-negative bacteria, stimulates macrophages to release large quantities of tumor necrosis factor (TNF) and interleukin-1 (IL-1), which can precipitate tissue injury and lethal shock (endotoxemia). Antagonists of TNF and IL-1 have shown limited efficacy in clinical trials, possibly because these cytokines are early mediators in pathogenesis. Here a potential late mediator of lethality is identified and characterized in a mouse model. High mobility group-1 (HMG-1) protein was found to be released by cultured macrophages more than 8 hours after stimulation with endotoxin, TNF, or IL-1. Mice showed increased serum levels of HMG-1 from 8 to 32 hours after endotoxin exposure. Delayed administration of antibodies to HMG-1 attenuated endotoxin lethality in mice, and administration of HMG-1 itself was lethal. Septic patients who succumbed to infection had increased serum HMG-1 levels, suggesting that this protein warrants investigation as a therapeutic target.

1 Department of Emergency Medicine and
2 Department of Surgery, North Shore University Hospital-New York University School of Medicine, Manhasset, NY 11030, USA.
3 The Picower Institute for Medical Research, Manhasset, NY 11030, USA.
4 Department of Surgery, Klinicum Grosshadern, Ludwig-Maximilians University, Munich, Germany.
5 Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
6 Department of Infectious Disease, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
7 Department of Rheumatology, Astrid Lindgren's Children's Hospital, Karolinska Institute, Stockholm, Sweden.
*   To whom correspondence should be addressed. E-mail: hwang{at}picower.edu


Read the Full Text





ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)